Definitive Contract W911SR21C0025
Award Date 1/11/21
Potential Completion Date 7/10/21
Potential Value $167K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
Total Small Business
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
STTR Phase I
Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed-price purchase order contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Zymeron Corporation, a minority-owned, for-profit biotechnology company, under the Small Business Innovation Research (SBIR) Program Phase I. The contract, valued at $197,000.00, is for research and development services related to an unspecified biomedical or public health initiative. As a total small business set-aside, this award aligns with Zymeron's...
- This contract was awarded by the Department of the Army Materiel Command TACOM Life Cycle Management Command to Zymeron Corporation, a minority-owned small business. The contract is for Phase I SBIR (Small Business Innovation Research) research, with a firm fixed-price contract type and a potential value of $162,482.83. Zymeron is a biotechnology company that focuses on developing innovative technologies in areas such as protein degradation, antibacterials, antivirals, and drug delivery systems....
- This is a firm fixed-price purchase order awarded to Zymeron Corporation, a minority-owned small business, under the Department of the Army Medical Command's Small Business Innovation Research (SBIR) program. The $250,000.00 Phase I contract is for the research and development of a "Novel Aerosol Therapy for Immediate and Sustained ARDS Management". Zymeron, a biotechnology company focused on areas like drug delivery systems, will perform this medical research at its facilities in...
- This is a $299,998.00 Firm Fixed Price contract awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Zymeron Corporation, a Minority Owned small business, under the Small Business Innovation Research (SBIR) program. The contract is for Phase I research and development related to "Combinatory Treatment Modalities Utilizing Radiation to Locally Activate or Release Systemically Delivered Therapeutics", as part of SBIR Topic...
- This is a $1,484,722.00 Cost Plus Fixed Fee contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Zymeron Corporation, a minority-owned small business located in Research Triangle Park, North Carolina. The contract was awarded under DARPA's Small Business Innovation Research (SBIR) program, Phase II, for the development of an "Automated Partial Occlusion for Truncal Hemorrhage Control" technology. This Phase II award builds upon earlier SBIR work and is...
- This is a Small Business Innovation Research (SBIR) Phase II award from the U.S. Army Medical Command (MEDCOM) to Zymeron Corporation, a minority-owned small business located in Research Triangle Park, North Carolina. The $2,999,992.85 Firm Fixed Price contract is for the "Development for a Novel Countermeasure, RadioDefender, as a Radioprotector for Hematopoietic Acute Radiation Syndrome". This contract is focused on delivering an innovative medical research and development solution...
- This is a $224,999 firm fixed-price contract awarded to Zymeron Corporation, a minority-owned small business, by the Defense Advanced Research Projects Agency (DARPA) under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development of a lab-on-chip microfiltering and imaging device for rapid and automated sterility testing. This effort aligns with DARPA's mission to provide game-changing capabilities to the warfighter and its focus on leveraging small...
- <p>The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $300,000 Firm Fixed Price Definitive Contract to Zymeron Corporation to develop Point-of-Care Diagnostics for Antimicrobial Resistant Enteric Bacterial and Parasitic Pathogens. The work will be performed in Research Triangle Park, North Carolina over a one year period ending June 30, 2023. No subcontractors were identified.</p>
- Zymeron Corporation was awarded a $400,000 firm fixed price definitive contract by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to develop user-friendly technologies and devices to create an at-home Hepatitis C virus test under the Small Business Innovation Research Program Topic 441. As a small business concern, Zymeron will conduct the research and development effort at its facilities in Research Triangle Park, North Carolina through...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $300,000.00 firm-fixed-price definitive contract to Zymeron Corporation, a minority-owned small business, to provide rapid point-of-care tests to quantify hepatitis C virus. The contract has an estimated completion date of August 30, 2022 and was awarded on August 31, 2021. Zymeron is a research-based biotechnology company that develops innovative technologies...